KLCM Advisors’s DexCom DXCM Stock Holding History

KLCM Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$521K	Hold	6,037	–	–	0.04%	178
2026 Q2	$407K	Hold	6,037	–	–	0.03%	199
2026 Q1	$379K	Hold	6,037	–	–	0.03%	188
2025 Q4	$401K	Buy	+6,037	New	+$390K	0.03%	170

Other funds holding DXCM

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

KLCM Advisors's DXCM Position: Q3 2026 in Review

KLCM Advisors held its DexCom (DXCM) position steady in Q3 2026 at 6,037 shares worth $521K. The position accounts for 0.04% of the portfolio, ranked #178.

KLCM Advisors first reported a position in DXCM in Q4 2025 and has held it in 4 quarters since. 832 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

KLCM Advisors held 6,037 shares of DexCom worth $521K as of Q3 2026.
KLCM Advisors left its DexCom share count unchanged in Q3 2026.
DexCom made up 0.04% of KLCM Advisors's portfolio in Q3 2026, its #178 holding.
KLCM Advisors first reported a position in DexCom in Q4 2025 and has held it in 4 quarters since.
832 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on KLCM Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.